Chikungunya virus: Clinical aspects and treatment

Memorias do Instituto Oswaldo Cruz

Volumn 112, Issue 8, 2017, Pages 523-531

  da Cunha, Rivaldo V ^a,b   Trinta, Karen S ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Chikungunya; Clinical aspects; Diagnosis; Review; Treatment

Indexed keywords

AEDES; ANIMAL; BRAZIL; CHIKUNGUNYA FEVER; HUMAN; VIROLOGY;

AEDES; ANIMALS; BRAZIL; CHIKUNGUNYA FEVER; HUMANS;

EID: 85026744818     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760170044     Document Type: Review

References (49)

1. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Bec-quart JP, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007; 44(11):1401-7.
2. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005; 114(1-2): 29-36.
3. Brito CAA, vonSohsten AKA, Leitão CCS, Brito RCCM, Valadares LDA, Fonte CAM, et al. Pharmacological pain treatment in chikungunya: a guideline. Rev Soc Bras Med Trop. 2016; 49(6): 668-79.
4. Brouard C, Bernillon P, Quatresous I, Pillonel J, Assa Al, De Valk H, et al. Estimated risk of chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion. 2008; 48(7): 1333-41.
5. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2012; 140(5): 842-50.
6. Cleton N, Koopmansa M, Reimerinka J, Godekea G-J, Reusken C. Come fly with me: review of clinically important arboviruses for global travelers. J Clin Virol 2012; 55(3): 191-203.
7. Coffey L, Failloux A, Weaver C. Chikungunya virus–vector interactions. Viruses. 2014; 6(11): 4628-63.
8. Crosby L, Perreau C, Madeux B, Cossic J, Armand C, Herrmann-Storke C, et al. Severe manifestations of Chikungunya virus in critically ill patients during the 2013–2014 Caribbean outbreak. Int J Infect Dis. 2016; 48: 78-80.
9. Cunha RV, Trinta KS, Montalbano CA, Sucupira MVF, Lima MM, Marques E, et al. Seroprevalence of Chikungunya virus in a rural community of Brazil. PLOS Negl Trop Dis. 2017; 11(1): e0005319.
10. Gerardin P, Baraug, Michault A, Bintner M, Randrianaivo H, Choker G, et al. Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Réunion. PLoS Med. 2008; 5(3): e60.
11. Harrison VR, Eckels KH, Bartelloni PJ, Hampton C. Production and evaluation of a formalin-killed chikungunya vaccine. J Immunol. 1971; 107(3): 643-7.
12. Hassing RJ, Leparc-Goffart I, Tolou H, van Doornum G, van Genderen PJ. Cross-reactivity of antibodies to viruses belonging to the Sem-liki Forest serocomplex. Euro Surveill. 2010; 15(23): pii:19588.
13. IBGE – Instituto Brasileiro de Geografia e Estatística [Internet] 2016 [accessed 2016 Oct] Available from: http://www.ibge.gov.br/home/default.php.
14. Kam YW, Ong EK, Rénia L, Tong JC, Ng LF. Immuno-biology of chikungunya and implications for disease intervention. Microbes Infect. 2009; 11(14-15): 1186-96.
15. Kuan G, Ramirez S, Gresh L, Ojeda S, Melendez M, Sanchez N, et al. Seroprevalence of anti-chikungunya virus antibodies in children and adults in Managua, Nicaragua, after the first chikungunya epidemic, 2014–2015. PLoS Negl Trop Dis. 2016; 10(6): e0004773.
16. Kumar NP, Suresh A, Vanamail P, Sabesan S, Krishnamoorthy KG, Mathew J, et al. Chikungunya virus outbreak in Kerala, India, 2007: a seroprevalence study. Mem Inst Oswaldo Cruz. 2011; 106(8): 912-6.
17. Lo Presti A, Lai A, Cella E, Zehender G, Ciccozzi M. Chikungunya virus, epidemiology, clinics and phylogenesis: a review. Asian Pac J Trop Med. 2014; 7(12): 925-32.
18. Lopes N, Nozawa C. Características gerais e epidemiologia dos arbovírus emergentes no Brasil. Rev Pan-Amaz Saude. 2014; 5(3): 55-64.
19. Lum FM, Ng LF. Cellular and molecular mechanisms of chikungunya pathogenesis. Antiviral Res. 2015; 120: 165-74.
20. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010; 104(6): 392-9.
21. Mercado M, Acosta-Reyes J, Parra E, Pardo L, Rico A, Campo A, et al. Clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in Colombia, 2014 to 2015. Euro Surveill. 2016; 21(22).
22. MS – Ministério da Saúde. Boletim Epidemiológico Secretaria de Vigilância em Saúde. 2015; 46(5) [Internet] 2015 [accessed 2016 Oct]. Available from: http://portalsaude.saude.gov.br/images/pdf/2015/fevereiro/11/Boletim-Dengue-SE04-2015..pdf.
23. MS – Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Preparação e resposta à introdução do vírus chikungunya no Brasil [Internet] 2014 [acessed 2016 Oct] Available from: http://bvsms.saude.gov.br/bvs/publicacoes/preparacao_resposta_virus_chikungunya_brasil.pdf.
24. Nunes MRT, Faria NR, Vasconcelos JM, Golding N, Kraemer MUG, Oliveira LF, et al. Emergence and potential for spread of chikungunya virus in Brazil. BMC Med. 2015; 13: 102.
25. OPAS/OMS – Organización Panamericana de la Salud/Organización Mundial de la Salud. Alerta Epidemiológica. Fiebre por chikungunya [Internet] 2013 [accessed 2016 Oct]. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=23807&Itemid.
26. PAHO – Pan American Health Organization. Countries/territories with autochthonous transmission or imported cases in the Americas – EW 1 – 2015 [Internet] 2015 [accessed 2016 Oct]. Available from: http://www.paho.org/hq/images/stories/AD/HSD/IR/Viral_Dis-eases/Chikungunya/CHIKV-Data-Caribbean-2016-EW-1.jpg.
27. Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis. 2008; 14(3): 416-22.
28. Parola P, Simon F, Oliver M. Tenosynovitis and vascular disorders associated with chikungunya virus–related rheumatism. Clin Infect Dis. 2007; 45(6): 801-2.
29. Petersen LR, Powers AM. Chikungunya: epidemiology. F1000Res. 2016; 5(F1000 Faculty Rev): 82.
30. Powers AM, and Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007; 88(Pt 9): 2363-77.
31. Queyriaux B, Simon F, Grandadam M, Michel R, Tolou H, Boutin JP. Clinical burden of chikungunya virus infection. Lancet Infect Dis. 2008; 8(1): 2-3.
32. Ramachandran V, Malaisamy M, Ponnaiah M, Kaliaperuaml K, Vad-ivoo S, Gupte MD. Impact of chikungunya on health related quality of life Chennai, South India. PLoS One. 2012; 7(12): e51519.
33. Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005–2006. Am J Trop Med Hyg. 2007; 77(4): 727-31.
34. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955; 49 (1): 28-32.
35. Rodrigues FN, Lourenço J, Cerqueira EM, Lima MM, Pybus O, Alcantara LC. Epidemiology of chikungunya virus in Bahia, Brazil, 2014–2015. PLoS Curr. 2016; 1(8): pii: ecurrents.outbreaks. c97507e3e48efb946401755d468c28b2.
36. Sam IC, Kümmerer BM, Chan YF, Roques P, Drosten C, AbuBakar S. Updates on chikungunya epidemiology, clinical disease, and diagnostics. Vector Borne Zoonotic Dis. 2015; 15(4): 223-30.
37. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006; 3(7): e263.
38. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010; 8: 491-500.
39. Seetharam KA, Sridevi K, Vidyasagar P. Cutaneous manifestations of chikungunya fever. Indian Pediatr. 2012; 49(1): 51-3.
40. Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, et al. Seroprevalence of chikungunya virus infection on Grande Comore Island, Union of the Comoros, 2005. Am J Trop Med Hyg. 2007; 76(6): 1189-93.
41. Simmons G, Brès V, Lu K, Liss NM, Brambilla DJ, RyffKR, et al. High incidence of chikungunya virus and frequency of viremic blood donations during epidemic, Puerto Rico, USA, 2014. Emerg Infecti Dis. 2016; 22(7): 1221-8.
42. Simon F, Javelle E, Cabie A, Bouquillard E, Troisgros O, Gentile G, et al. French guidelines for the management of chikungunya (acute and persistent presentations). Med Mal Infect. 2015; 45(7): 243-63.
43. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et al. Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoSNegl Trop Dis. 2009; 3(3): e389.
44. Sissoko, D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet JL, et al. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005–2006: a population-based survey. PLoS One. 2008; 3(8): e3066.
45. Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013; 99(3): 345-70.
46. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007; 3: e201
47. Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: case report and review of the literature. Semin Arthritis and Rheum. 2013; 43(2): 273-8.
48. White A, Berman S, Lowenthal JP. Comparative immunogenicities of chikungunya vaccines propagated in monkey kidney monolay-ers and chick embryo suspension cultures. Appl. Microbiol. 1972; 23(5): 951-2.
49. Yoon I-K, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, et al. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines. PLoS Negl Trop Dis. 2015; 9(5): e0003764.